SARS-CoV-2 seroprevalence among 7950 healthcare workers in the Region of Southern Denmark

被引:6
|
作者
von Huth, Sebastian [1 ,2 ,3 ]
Lillevang, Soren Thue [4 ]
Roge, Birgit Thorup [3 ]
Madsen, Jonna Skov [5 ,6 ]
Mogensen, Christian Backer [6 ,7 ]
Coia, John Eugenio [6 ,8 ]
Moller, Soren [9 ,10 ]
Justesen, Ulrik Stenz [9 ,11 ]
Johansen, Isik Somuncu [1 ,2 ,9 ]
机构
[1] Odense Univ Hosp, Dept Infect Dis, JB Winslows Vej 4,Indgang 18 Penthouse 2 Sal, DK-5000 Odense C, Denmark
[2] Univ Southern Denmark, Res Unit Infect Dis, JB Winslows Vej 4,Indgang 18 Penthouse 2 Sal, DK-5000 Odense C, Denmark
[3] Lillebaelt Hosp, Dept Internal Med, Sygehusvej 24, DK-6000 Kolding, Denmark
[4] Odense Univ Hosp, Dept Clin Immunol, JB Winslows Vej 4, DK-5000 Odense C, Denmark
[5] Lillebaelt Hosp, Dept Biochem & Immunol, Beriderbakken 4, DK-7100 Vejle, Denmark
[6] Univ Southern Denmark, Dept Reg Hlth Res IRS, JB Winslows Vej 19,3, DK-5000 Odense C, Denmark
[7] Hosp Sonderjylland, Dept Emergency Med, Kresten Philipsens Vej 15, DK-6200 Aabenraa, Denmark
[8] Hosp South West Jutland, Dept Clin Microbiol, Finsensgade 35,Bygning F,1, DK-6700 Esbjerg, Denmark
[9] Univ Southern Denmark, Dept Clin Res, JB Winslows Vej 19,3, DK-5000 Odense C, Denmark
[10] Odense Univ Hosp, OPEN Open Patient Data Explorat Network, JB Winslows Vej 4, DK-5000 Odense C, Denmark
[11] Odense Univ Hosp, Dept Clin Microbiol, JB Winslows Vej 21,2, DK-5000 Odense C, Denmark
关键词
SARS-CoV-2; COVID-19; Healthcare workers; Seroprevalence; Antibodies; Epidemiology; COVID-19; PREVALENCE;
D O I
10.1016/j.ijid.2021.09.023
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: Healthcare workers (HCWs) carry a pronounced risk of acquiring severe acute respiratory syn-drome coronavirus 2 (SARS-CoV-2) infection. The aim of this study was to determine the seroprevalence and potential risk factors of SARS-CoV-2 infection among HCWs in the Region of Southern Denmark after the first pandemic wave in the spring of 2020. Methods: This was an observational study conducted between May and June 2020. SARS-CoV-2 IgG and IgM antibodies were measured in plasma. Participants were asked to complete a questionnaire consisting of demographic information, risk factors, and COVID-19-related symptoms. Results: A total of 7950 HCWs participated. The seroprevalence of SARS-CoV-2 antibodies was 2.1% (95% confidence interval (CI) 1.8-2.4%). Seropositive participants were significantly older (mean age 48.9 years vs 46.7 years in seronegative participants, P = 0.022) and a higher percentage had experienced at least one symptom of COVID-19 ( P < 0.001). The seroprevalence was significantly higher among HCWs working on dedicated COVID-19 wards (3.5%; OR 2.02, 95% CI 1.4 4-2.84). Seroprevalence was significantly related to 11-50 close physical contacts per day outside work (OR 1.54, 95% CI 1.07-2.22). Conclusions: The prevalence of SARS-CoV-2 antibodies was low in HCWs. However, the occupational risk of contracting the infection was found to be higher for those working on dedicated COVID-19 wards. Further, the results imply that attention should be paid to occupational risk factors in planning pandemic preparedness. (c) 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页码:96 / 102
页数:7
相关论文
共 50 条
  • [41] Seroprevalence of Antibodies Against SARS-CoV-2 Among Health Care Workers in Mumbai, India
    Kumar, Nishant
    Bhartiya, Shibal
    Desai, Shashank
    Mutha, Amit
    Beldar, Amit
    Singh, Tarundeep
    ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH, 2021, 33 (01) : 126 - 128
  • [42] Differences in risk for SARS-CoV-2 infection among healthcare workers
    Elfstrom, K. Miriam
    Blomqvist, Jonas
    Nilsson, Peter
    Hober, Sophia
    Pin, Elisa
    Manberg, Anna
    Pimenoff, Ville N.
    Muhr, Laila Sara Arroyo
    Lundgren, Kalle Conneryd
    Dillner, Joakim
    PREVENTIVE MEDICINE REPORTS, 2021, 24
  • [43] SARS-CoV-2 Seroprevalence Among First Responders in Northeastern Ohio, 2020
    Zhang, Xiaochun
    Saade, Elie
    Noguez, Jaime H.
    Schmotzer, Christine
    PUBLIC HEALTH REPORTS, 2023, 138 (01) : 140 - 148
  • [44] A cross-sectional study of SARS-CoV-2 seroprevalence among asymptomatic healthcare workers in a tertiary healthcare centre: Assessing the impact of PPE guidelines
    Wattal, Chand
    Oberoi, Jaswinder Kaur
    Goel, Neeraj
    Datta, Sanghamitra
    Raveendran, Reena
    Rao, Brijendra Kumar
    Kumar, Reena
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2021, 39 (04) : 528 - 533
  • [45] Seroprevalence of neutralizing antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among healthcare workers in Makkah, Saudi Arabia
    Ahmed, Waleed A.
    Dada, Ashraf
    Alshukairi, Abeer N.
    Sohrab, Sayed S.
    Faizo, Arwa A.
    Tolah, Ahmed M.
    El-Kafrawy, Sherif A.
    Bajrai, Leena H.
    Moalim, Hanan M.
    Aly, Mohamed H.
    Aboelazm, Ahmed F.
    Al-Hamzi, Mohammed A.
    Saeedi, Mohammed F.
    Alandijany, Thamir A.
    Azhar, Esam, I
    JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2021, 33 (03)
  • [46] Seroprevalence of SARS-CoV-2 antibodies among primary healthcare workers in the Republic of Srpska, Bosnia & Herzegovina: A cross-sectional study
    Knezevic, Darija
    Petkovic, Miroslav
    Bozic, Ljiljana
    Miljus, Natasa
    Mijovic, Biljana
    Acimovic, Jela
    Djakovic-Devic, Jelena
    Puhalo-Sladoje, Dragana
    Masic, Srdjan
    Spaic, Dragan
    Todorovic, Nevena
    Pilipovic-Broceta, Natasa
    Petrovic, Verica
    Bokonjic, Dejan
    Stojiljkovic, Milos P.
    Skrbic, Ranko
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2022, 69 (01) : 18 - 26
  • [47] SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021
    Murhekar, Manoj, V
    Bhatnagar, Tarun
    Thangaraj, Jeromie Wesley Vivian
    Saravanakumar, V
    Kumar, Muthusamy Santhosh
    Selvaraju, Sriram
    Rade, Kiran
    Kumar, C. P. Girish
    Sabarinathan, R.
    Turuk, Alka
    Asthana, Smita
    Balachandar, Rakesh
    Bangar, Sampada Dipak
    Bansal, Avi Kumar
    Chopra, Vishal
    Das, Dasarathi
    Deb, Alok Kumar
    Devi, Kangjam Rekha
    Dhikav, Vikas
    Dwivedi, Gaurav Raj
    Khan, S. Muhammad Salim
    Kumar, M. Sunil
    Laxmaiah, Avula
    Madhukar, Major
    Mahapatra, Amarendra
    Rangaraju, Chethana
    Turuk, Jyotirmayee
    Yadav, Rajiv
    Andhalkar, Rushikesh
    Arunraj, K.
    Bharadwaj, Dinesh Kumar
    Bharti, Pravin
    Bhattacharya, Debdutta
    Bhat, Jyothi
    Chahal, Ashrafjit S.
    Chakraborty, Debjit
    Chaudhury, Anshuman
    Deval, Hirawati
    Dhatrak, Sarang
    Dayal, Rakesh
    Elantamilan, D.
    Giridharan, Prathiksha
    Haq, Inaamul
    Hudda, Ramesh Kumar
    Jagjeevan, Babu
    Kalliath, Arshad
    Kanungo, Srikanta
    Krishnan, Nivethitha N.
    Kshatri, Jaya Singh
    Kumar, Alok
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 108 : 145 - 155
  • [48] Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina
    Halili, Rrezart
    Bunjaku, Jeta
    Gashi, Bujar
    Hoxha, Teuta
    Kamberi, Agron
    Hoti, Nexhmedin
    Agahi, Riaz
    Basha, Vlora
    Berisha, Visar
    Hoxha, Ilir
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [49] Prevalence of SARS-CoV-2 antibodies in pediatric healthcare workers
    Morris, Claudia R.
    Sullivan, Patrick
    Mantus, Grace
    Sanchez, Travis
    Zlotorzynska, Maria
    Hanberry, Bradley
    Iyer, Srikant
    Heilman, Stacy
    Camacho-Gonzalez, Andres
    Figueroa, Janet
    Manoranjithan, Shaminy
    Leake, Deborah
    Mendis, Reshika
    Cleeton, Rebecca
    Chen, Christie
    Krieger, Rachel
    Bush, Patricia
    Hughes, Tiffany
    Little, Wendalyn K.
    Suthar, Mehul S.
    Wrammert, Jens
    Vos, Miriam B.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 105 : 474 - 481
  • [50] The Risk of SARS-CoV-2 Infection Among Healthcare Workers
    Madran, Bahar
    Keske, Siran
    Besli, Yesim
    Bozkurt, Ismail
    Ergonul, Onder
    INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2020, 2 (02): : 54 - 60